Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/175676
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDarbà, Josep-
dc.contributor.authorMarsà, Alícia-
dc.date.accessioned2021-03-24T11:43:15Z-
dc.date.available2022-01-31T06:10:21Z-
dc.date.issued2021-01-
dc.identifier.issn1473-7167-
dc.identifier.urihttp://hdl.handle.net/2445/175676-
dc.description.abstractCancer is annually responsible for millions of deaths in Europe and billions of euros in productivity losses; the estimated mortality rate of lymphoma was of 7.07 per 100,000 individuals in Spain in 2018. This study aimed to evaluate the burden that lymphoma mortality represents for the Spanish society.-
dc.format.extent6 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherInforma Healthcare-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/14737167.2020.1769478-
dc.relation.ispartofExpert Review of Pharmacoeconomics & Outcomes Research, 2021, vol. 21, num. 1, p. 87-92-
dc.relation.urihttps://doi.org/10.1080/14737167.2020.1769478-
dc.rights(c) Informa Healthcare, 2021-
dc.sourceArticles publicats en revistes (Economia)-
dc.subject.classificationLimfomes-
dc.subject.classificationMalaltia de Hodgkin-
dc.subject.classificationMortalitat-
dc.subject.classificationInvestigació mèdica-
dc.subject.otherLymphomas-
dc.subject.otherHodgkin's disease-
dc.subject.otherMortality-
dc.subject.otherMedicine research-
dc.titleBurden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec701434-
dc.date.updated2021-03-24T11:43:15Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
701434.pdf393.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.